Glaukos (GKOS)
(Real Time Quote from BATS)
$125.28 USD
+2.51 (2.04%)
Updated Jul 23, 2024 10:40 AM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Price, Consensus and EPS Surprise
GKOS 125.28 +2.51(2.04%)
Will GKOS be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for GKOS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for GKOS
Glaukos (GKOS) Gains 51.9% YTD: What's Driving the Stock?
Will WATCHMAN Sales Aid Boston Scientific's (BSX) Q2 Earnings?
GKOS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is a Beat Likely for Edwards Lifesciences (EW) in Q2 Earnings?
Strength Seen in CVRx (CVRX): Can Its 19.0% Jump Turn into More Strength?
Baxter (BAX) Shares Rise 2.4% in July: Will It Go Higher?
Other News for GKOS
Healthcare 2024 Second Half Outlook
Glaukos price target raised by $16 at Truist, here's why
Glaukos to Release Second Quarter 2024 Financial Results after Market Close on July 31
Glaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its 2.75% Convertible Senior Notes Due 2027 for Common Stock
4 constructive medical devices stocks - BTIG